Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy

Introduction There is no consensus on how to investigate men with negative transrectal ultrasound guided prostate biopsy (TRUS-B) but ongoing suspicion of cancer. Three strategies used are transperineal (TP-B), transrectal saturation (TS-B) and MRI-guided biopsy (MRI-B). We compared cancer yields of these strategies. Methods Papers were identified by search of Pubmed, Embase and Ovid Medline. Included studies investigated biopsy diagnostic yield in men with at least one negative TRUS-B and ongoing suspicion of prostate cancer. Data including age, PSA, number of previous biopsy episodes, number of cores at re-biopsy, cancer yield, and Gleason score of detected cancers were extracted. Meta-regression analyses were used to analyse the data. Results Forty-six studies were included; 12 of TS-B, 14 of TP-B, and 20 of MRI-B, representing 4,657 patients. Mean patient age, PSA and number of previous biopsy episodes were similar between the strategies. The mean number of biopsy cores obtained by TP-B and TS-B were greater than MRI-B. Cancer detection rates were 30·0%, 36·8%, and 37·6% for TS-B, TP-B, and MRI-B respectively. Meta-regression analysis showed that MRI-B had significantly higher cancer detection than TS-B. There were no significant differences however between MRI-B and TP-B, or TP-B and TS-B. In a sensitivity analysis incorporating number of previous biopsy episodes (36 studies) the difference between MRI-B and TP-B was not maintained resulting in no significant difference in cancer detection between the groups. There were no significant differences in median Gleason scores detected comparing the three strategies. Conclusions In the re-biopsy setting, it is unclear which strategy offers the highest cancer detection rate. MRI-B may potentially detect more prostate cancers than other modalities and can achieve this with fewer biopsy cores. However, well–designed prospective studies with standardised outcome measures are needed to accurately compare modalities and define an optimum re-biopsy approach.

[1]  L. Klotz,et al.  Active Surveillance for Low-Risk Prostate Cancer , 2015, Current Urology Reports.

[2]  Thomas Hambrock,et al.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.

[3]  J. Nesland,et al.  Transperineal prostate biopsy detects significant cancer in patients with elevated prostate‐specific antigen (PSA) levels and previous negative transrectal biopsies , 2012, BJU international.

[4]  D. Schilling,et al.  MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy , 2012, World Journal of Urology.

[5]  Masood Khan,et al.  The role of a standardized 36 core template‐assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography‐guided prostate biopsies , 2012, BJU international.

[6]  E. Sala,et al.  The emerging role of diffusion-weighted MRI in prostate cancer management , 2012, Nature Reviews Urology.

[7]  A. Doble,et al.  Risk profiles of prostate cancers identified from UK primary care using national referral guidelines , 2012, British Journal of Cancer.

[8]  Georgios Sakas,et al.  A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. , 2011, The Journal of urology.

[9]  U. Capitanio,et al.  The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme. , 2011, European urology.

[10]  Pingkun Yan,et al.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.

[11]  K. Fareed,et al.  Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. , 2011, The Journal of urology.

[12]  J Stephen Jones,et al.  Prostate cancer detection after a negative prostate biopsy: Lessons learnt in the Cleveland Clinic experience , 2011, International journal of urology : official journal of the Japanese Urological Association.

[13]  Ralph Strecker,et al.  Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. , 2011, Radiology.

[14]  F. Montorsi,et al.  Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? , 2011, Urology.

[15]  B. Barbiroli,et al.  Accuracy of MRI/MRSI‐based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy , 2010, NMR in biomedicine.

[16]  Tsuyoshi Mitake,et al.  Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data , 2010, International journal of urology : official journal of the Japanese Urological Association.

[17]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[18]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[19]  F. Montorsi,et al.  Is extended and saturation biopsy necessary? , 2010, International journal of urology : official journal of the Japanese Urological Association.

[20]  V. Ficarra,et al.  Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography‐guided transperineal saturation biopsies of the prostate , 2010, BJU international.

[21]  Roberto Passariello,et al.  Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.

[22]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[23]  K. Wallner,et al.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.

[24]  K. Wallner,et al.  Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. , 2009, Urology.

[25]  Mark Emberton,et al.  THE ROLE OF MAGNETIC RESONANCE IMAGING IN TARGETING PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PROSTATE‐SPECIFIC ANTIGEN LEVELS , 2009, BJU international.

[26]  Olivier Rouvière,et al.  Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy , 2009, European Radiology.

[27]  T. Habuchi,et al.  Characterization of prostate cancer detected at repeat biopsy , 2008, BMC urology.

[28]  B. K. Park,et al.  Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative radiology.

[29]  Katarzyna J Macura,et al.  MR-guided biopsy of the prostate: an overview of techniques and a systematic review. , 2008, European urology.

[30]  D. Regge,et al.  Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. , 2008, Clinical radiology.

[31]  R. Kuefer,et al.  Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction , 2008, BJU international.

[32]  Peter Guion,et al.  Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.

[33]  A. Zisman,et al.  Saturation prostate biopsy in high risk patients after multiple previous negative biopsies. , 2008, Urology.

[34]  F. Aragona,et al.  Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. , 2007, Urology.

[35]  Chao-yuan Huang,et al.  Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in taiwan. , 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

[36]  Rodolfo Montironi,et al.  Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. , 2007, European urology.

[37]  M. Terris,et al.  High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. , 2007, Urology.

[38]  S. Phongkitkarun,et al.  Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[39]  Ashutosh Kumar Singh,et al.  Magnetic resonance imaging‐directed transrectal ultrasonography‐guided biopsies in patients at risk of prostate cancer , 2007, BJU international.

[40]  K. Wallner,et al.  Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. , 2006, European urology.

[41]  A. Henderson,et al.  Extensive transperineal template biopsies of prostate: modified technique and results. , 2006, Urology.

[42]  Heinz-Peter Schlemmer,et al.  MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.

[43]  B. Moran,et al.  Re-biopsy of the prostate using a stereotactic transperineal technique. , 2006, The Journal of urology.

[44]  A. Haese*,et al.  High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. , 2006, European urology.

[45]  Susanne Hempel,et al.  Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. , 2006, The Journal of urology.

[46]  F. Zattoni,et al.  Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings. , 2006, Urology.

[47]  B. Kiefer,et al.  Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device , 2006, European Radiology.

[48]  J. Kurhanewicz,et al.  Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.

[49]  Takashi Arakawa,et al.  Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. , 2005, Urology.

[50]  N. Shinohara,et al.  Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound‐guided template prostate biopsy , 2005, Cancer.

[51]  M. Zerbib,et al.  Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.

[52]  Paul R Young,et al.  Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. , 2005, Urology.

[53]  S. Zangos,et al.  Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies , 2005, European Radiology.

[54]  Amit Patel,et al.  Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. , 2004, The Journal of urology.

[55]  W S Ng,et al.  Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.

[56]  P. Schellhammer,et al.  The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies. , 2002, Clinical prostate cancer.

[57]  Bernd Hamm,et al.  Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.

[58]  L. Klotz,et al.  Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. , 2002, Urology.

[59]  William J Catalona,et al.  Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.

[60]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[61]  A. Weaver,et al.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. , 2001, The Journal of urology.

[62]  P. Young,et al.  Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. , 2001, The Journal of urology.

[63]  A. D'Amico,et al.  Transperineal magnetic resonance image guided prostate biopsy. , 2000, The Journal of urology.

[64]  K. Badani,et al.  Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.

[65]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[66]  R. Shackman,et al.  BIOPSY , 1961 .

[67]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[68]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[69]  Thomas Wiegel,et al.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.

[70]  B. Kulovac,et al.  Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy. , 2011, Medicinski arhiv.

[71]  J. Jones,et al.  Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. , 2004, Urology.

[72]  T. Koyanagi,et al.  Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy , 2004, The Prostate.

[73]  C. Amling,et al.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.

[74]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.